Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine

Open Access

Peer-reviewed

Research Article

Isabel Leroux-Roels,

Affiliation Centre for Vaccinology, Ghent University and Hospital, Ghent, Belgium
⨯
Roger Bernhard,

Affiliation GlaxoSmithKline Biologicals, Dresden, Germany
⨯
Pascal Gérard,

Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
⨯
Mamadou Dramé,

Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
⨯
Emmanuel Hanon,

Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
⨯
Geert Leroux-Roels

*E-mail: Geert.LerouxRoels@UGent.be

Affiliation Centre for Vaccinology, Ghent University and Hospital, Ghent, Belgium
⨯

x

Viewed

Powered by Altmetric

Questions or concerns about usage data? Please let us know.

Print

H5N1
Is the Subject Area "H5N1" applicable to this article?

Thanks for your feedback.
Viral vaccines
Is the Subject Area "Viral vaccines" applicable to this article?

Thanks for your feedback.
Recombinant vaccines
Is the Subject Area "Recombinant vaccines" applicable to this article?

Thanks for your feedback.
Immunologic adjuvants
Is the Subject Area "Immunologic adjuvants" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Antigens
Is the Subject Area "Antigens" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
Immunity
Is the Subject Area "Immunity" applicable to this article?

Thanks for your feedback.